(Q61907196)

English

Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Effect of Dihydromirycetin Administration on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Patients With Type 2 Diabetes Mellitus (English)

0 references

0 references

0 references

1 February 2019

0 references

end time

30 September 2020

0 references

number of participants

24

0 references

research intervention

metformin

0 references

clinical trial phase

phase II clinical trial

0 references

minimum age

30 year

0 references

maximum age

60 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03606694

0 references

(Q61907196)

Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)